With approvals in siRNA technology, more ASOs hurtling towards human trials in neurology, and exciting headlines in Alzheimer’s and ALS, the draw of CNS targets for oligonucleotides has never been […]

Returning as the pinnacle event in the industry, the 4th Annual Gene Therapy for Neurological Disorders Summit Europe (6-8 June 2023, Amsterdam) enables you to bring your gene therapy to […]